Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Asymmetrical valve expansion after TAVR a cause for concern
Calcified debris can sometimes lead to stent frame issues that cause a patient's TAVR valve to expand asymmetrically. Few studies have explored the potential impact of valve asymmetry—until now.
FDA approves Boston Scientific leads for left bundle branch area pacing
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
FDA approves longer LumiGuide 3D navigation wire from Philips
The newly approved device comes in at 160 cm. Like the shorter LumiGuide device from Philips, it was designed to deliver real-time 3D visualization with light instead of X-rays.
Merit Medical to purchase Cook Medical’s lead management portfolio for $210M
Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.

TriVascular Technologies, Inc. Receives FDA Approval of the Ovation iX(TM) Abdominal Stent Graft System

TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the U.S. Food and Drug Administration (FDA) approved the Ovation iX Abdominal Stent Graft System. Delivery system enhancements of Ovation iX, which stands for integrated exchange, are designed to provide physicians with additional flexibility for even more predictable deployment and greater ease of use.

August 4, 2015

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2015 of $112.7 million, or $1.02 per diluted share. 

July 30, 2015

New release of CAAS IntraVascular for analysis of IVUS, NIRS-IVUS and OCT datasets

Pie Medical Imaging announces the release of CAAS IntraVascular 2.0, the dedicated software for analysis of IVUS, NIRS-IVUS and OCT datasets.

July 30, 2015

Siemens Healthcare Diagnostics introduces portable coagulation analyser for fast and reliable testing at the point of care

Siemens Healthcare Diagnostics has launched the hand-held and portable Xprecia Stride Coagulation Analyser to deliver fast, reliable testing in any clinical environment. 

July 28, 2015

Vital’s CT Myocardial Perfusion to Make Its U.S. Debut at SCCT 2015

Vital Images, Inc. (Vital) will debut its 510(k) FDA-cleared CT Myocardial Perfusion application at the 10 th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) in Las Vegas, July 16-19. 

July 14, 2015

Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system. 

July 13, 2015

HRS Doesn’t Miss a Beat with Cutting-edge Trials

The Heart Rhythm Society focused on the latest developments in electrophysiology and the management of patients with rhythm disorders and heart failure at its 2015 meeting on May 13-16 in Boston. The event included 12 late-breaking clinical trials.

July 7, 2015

American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke

Today, the American Heart Association/American Stroke Association (AHA/ASA) published new stroke treatment guidelines that recommend the use of stent retriever technology - such as Medtronic plc's (NYSE: MDT) SolitaireTM stent retriever device - in conjunction with the current standard of care, IV-tPA, as a first-line treatment for eligible patients.

June 30, 2015

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Cardiac Imaging

Asymmetrical valve expansion after TAVR a cause for concern

FDA approves Boston Scientific leads for left bundle branch area pacing

FDA approves longer LumiGuide 3D navigation wire from Philips

Merit Medical to purchase Cook Medical’s lead management portfolio for $210M

JACC editor excited by progress during a 'very important moment' for cardiology

Around the web